Skip to main content
NANO MRNA Co.,Ltd. logo

NANO MRNA Co.,Ltd. — Investor Relations & Filings

Ticker · 4571 ISIN · JP3651120002 LEI · 529900L2VA2GIFZQTG17 T Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2018-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4571

About NANO MRNA Co.,Ltd.

https://www.nanomrna.co.jp/

NANO MRNA Co., Ltd. is a biotechnology firm that operates as a platform company and an IP Generator specializing in mRNA-based medicine. The company focuses on creating and out-licensing intellectual property for novel therapeutics by connecting drug discovery seeds with medical and development needs. It leverages a proprietary drug delivery system (DDS) based on micellar nanoparticle technology to advance its pipeline. Key clinical programs include an mRNA therapy for osteoarthritis (RUNX1 mRNA) and an antisense oligonucleotide (ASO) for glioblastoma (TUG1 ASO). Evolving from its predecessor, NanoCarrier, the company combines a legacy of R&D in nanoparticle technology with a strategic focus on RNA drug discovery. It also co-developed and markets Comlex®, an antibacterial agent for ear, nose, and throat conditions.

Recent filings

Filing Released Lang Actions
四半期報告書－第22期第3四半期(2017/10/01－2017/12/31)
Interim / Quarterly Report
2018-02-14 Japanese
四半期報告書－第22期第2四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, including balance sheets, income statements, and cash flow analysis for the second quarter of the 22nd fiscal period. It is not an announcement or a certification, but the full report itself, fitting the definition of an Interim/Quarterly Report (IR). Q2 2018
2017-11-10 Japanese
四半期報告書－第22期第1四半期(2017/04/01－2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act. It contains detailed financial statements (Balance Sheet, Income Statement) for the first quarter of the 22nd fiscal period (April 1, 2017 to June 30, 2017). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. Q1 2018
2017-08-10 Japanese
有価証券報告書－第21期(2016/04/01－2017/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, business descriptions, and management information for the fiscal year ending March 31, 2017. It is a comprehensive annual filing submitted to the Kanto Local Finance Bureau, not an announcement or a summary. FY 2017
2017-06-26 Japanese
四半期報告書－第21期第3四半期(2016/10/01－2016/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet and income statement, for the third quarter of the 21st fiscal period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-02-14 Japanese
四半期報告書－第21期第2四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report
2016-11-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.